Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong Zang

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Chinese Clinical Oncology|March 27, 2015
Adaptive clinical trial designs in oncologyYong Zang, J Jack Lee
Genetic Epidemiology|October 20, 2011
Robust Mantel-Haenszel test under genetic model uncertainty allowing for covariates in case-control association studiesYong Zang, Wing Kam Fung
Statistics in Medicine|August 20, 2016
A robust two-stage design identifying the optimal biological dose for phase I/II clinical trialsYong Zang, J Jack Lee
Chinese Clinical Oncology|April 6, 2015
Adaptive clinical trial designs in oncologyYong Zang, J Jack Lee
Materials (Basel, Switzerland)|May 25, 2024
Research on the Hot Straightening Process of Medium-Thick Plates Based on Elastic-Viscoplastic Material ModelingZhanyuan Xue, Ben Guan, Yong Zang
Biostatistics (Oxford, England)|March 9, 2016
Optimal marker-strategy clinical trial design to detect predictive markers for targeted therapyYong Zang, Suyu Liu, Ying Yuan
Biometrics|February 16, 2024
A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparisonYong Zang, Peter F Thall, Ying Yuan
Clinical Trials (London, England)|May 22, 2014
Adaptive designs for identifying optimal biological dose for molecularly targeted agentsYong Zang, J Jack Lee, Ying Yuan
American Journal of Human Genetics|February 14, 2009
Tail strength to combine two p values: their correlation cannot be ignoredYong Zang, Wing K Fung, Gang Zheng
Pharmaceutical Statistics|April 11, 2023
Generalized phase I-II designs to increase long term therapeutic success ratePeter F Thall, Yong Zang, Ying Yuan
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Chinese Clinical Oncology|March 27, 2015
Adaptive clinical trial designs in oncologyYong Zang, J Jack Lee
Genetic Epidemiology|October 20, 2011
Robust Mantel-Haenszel test under genetic model uncertainty allowing for covariates in case-control association studiesYong Zang, Wing Kam Fung
Statistics in Medicine|August 20, 2016
A robust two-stage design identifying the optimal biological dose for phase I/II clinical trialsYong Zang, J Jack Lee
Chinese Clinical Oncology|April 6, 2015
Adaptive clinical trial designs in oncologyYong Zang, J Jack Lee
Materials (Basel, Switzerland)|May 25, 2024
Research on the Hot Straightening Process of Medium-Thick Plates Based on Elastic-Viscoplastic Material ModelingZhanyuan Xue, Ben Guan, Yong Zang
Biostatistics (Oxford, England)|March 9, 2016
Optimal marker-strategy clinical trial design to detect predictive markers for targeted therapyYong Zang, Suyu Liu, Ying Yuan
Biometrics|February 16, 2024
A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparisonYong Zang, Peter F Thall, Ying Yuan
Clinical Trials (London, England)|May 22, 2014
Adaptive designs for identifying optimal biological dose for molecularly targeted agentsYong Zang, J Jack Lee, Ying Yuan
American Journal of Human Genetics|February 14, 2009
Tail strength to combine two p values: their correlation cannot be ignoredYong Zang, Wing K Fung, Gang Zheng
Pharmaceutical Statistics|April 11, 2023
Generalized phase I-II designs to increase long term therapeutic success ratePeter F Thall, Yong Zang, Ying Yuan
Pageof 11